Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Barbara Stollfuß"'
Autor:
Barbara Stollfuss, Manuel Richter, Daniel Drömann, Hans Klose, Martin Schwaiblmair, Ekkehard Gruenig, Ralf Ewert, Martin C Kirchner, Frank Kleinjung, Valeska Irrgang, Christian Mueller
Publikováno v:
Journal of Medical Internet Research, Vol 23, Iss 10, p e25163 (2021)
BackgroundPulmonary arterial hypertension restricts the ability of patients to perform routine physical activities. As part of pulmonary arterial hypertension treatment, inhaled iloprost can be administered via a nebulizer that tracks inhalation beha
Externí odkaz:
https://doaj.org/article/e4736d1e589b4b1294dc44b69ddc1a3f
Autor:
Ingo Kleiter, Michael Lang, Judith Jeske, Christiane Norenberg, Barbara Stollfuß, Markus Schürks
Publikováno v:
BMC Neurology, Vol 17, Iss 1, Pp 1-14 (2017)
Abstract Background Maintaining patient adherence to disease modifying drugs in multiple sclerosis is a challenge, which can be improved by autoinjectors. The BETACONNECT® is a fully electronic autoinjector for the injection of interferon beta-1b (I
Externí odkaz:
https://doaj.org/article/288d665dec4a4bdbbd5974908df5d183
Autor:
Manuel J. Richter, Barbara Stollfuß, Alexander Roitenberg, Frank Kleinjung, Valentin Graeff, Sabine Berghaus, Christian Müller, Hossein-Ardeschir Ghofrani
Publikováno v:
Pulmonary Circulation, Vol 8 (2018)
Inhaled iloprost is an effective therapy for patients with pulmonary arterial hypertension (PAH); however, some patients experience extended inhalation times when using the V10 formulation (10.0 µg/mL) to deliver a 5 -µg dose (at mouthpiece) and ar
Externí odkaz:
https://doaj.org/article/4e94815674e24804bf6683c65e375b2c
Autor:
Daniel Drömann, Ekkehard Gruenig, Hans Klose, Manuel J. Richter, Barbara Stollfuss, Christian Mueller, Ralf Ewert, Martin Schwaiblmair, Valeska Irrgang, Martin C Kirchner, Frank Kleinjung
Publikováno v:
Journal of Medical Internet Research
Background Pulmonary arterial hypertension restricts the ability of patients to perform routine physical activities. As part of pulmonary arterial hypertension treatment, inhaled iloprost can be administered via a nebulizer that tracks inhalation beh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4045c471688ccc548f75f40b83c5812b
https://edoc.unibas.ch/87835/
https://edoc.unibas.ch/87835/
Autor:
Barbara Stollfuss, Manuel Richter, Daniel Drömann, Hans Klose, Martin Schwaiblmair, Ekkehard Gruenig, Ralf Ewert, Martin C Kirchner, Frank Kleinjung, Valeska Irrgang, Christian Mueller
BACKGROUND Pulmonary arterial hypertension restricts the ability of patients to perform routine physical activities. As part of pulmonary arterial hypertension treatment, inhaled iloprost can be administered via a nebulizer that tracks inhalation beh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d314b99e09451a6a2d99542dfc7f4314
https://doi.org/10.2196/preprints.25163
https://doi.org/10.2196/preprints.25163
Publikováno v:
JMIR Research Protocols
BACKGROUND Pulmonary arterial hypertension (PAH)—a progressive, ultimately fatal disease—patients often experience dyspnea, which can limit their daily physical activities. Iloprost is an inhaled therapy for PAH that has shown efficacy in clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c3e09b4943365885f5a16ce7fd0e08c
https://doi.org/10.2196/preprints.12144
https://doi.org/10.2196/preprints.12144
Autor:
Barbara Stollfuß, Hossein Ardeschir Ghofrani, Valentin Graeff, Manuel J. Richter, Sabine Berghaus, Alexander Roitenberg, Frank Kleinjung, Christian Müller
Publikováno v:
Pulmonary Circulation, Vol 8 (2018)
Pulmonary Circulation
Pulmonary Circulation
Inhaled iloprost is an effective therapy for patients with pulmonary arterial hypertension (PAH); however, some patients experience extended inhalation times when using the V10 formulation (10.0 µg/mL) to deliver a 5 -µg dose (at mouthpiece) and ar
Autor:
Barbara Stollfuß, Michael Lang, Markus Schürks, Christiane Norenberg, Judith Jeske, Ingo Kleiter
Publikováno v:
BMC Neurology, Vol 17, Iss 1, Pp 1-14 (2017)
BMC Neurology
BMC Neurology
Background Maintaining patient adherence to disease modifying drugs in multiple sclerosis is a challenge, which can be improved by autoinjectors. The BETACONNECT® is a fully electronic autoinjector for the injection of interferon beta-1b (IFN beta-1
Autor:
Valentin Graeff, Alexander Roitenberg, Barbara Stollfuß, Sabine Berghaus, Frank Kleinjung, Silke Gerlach, Manuel J. Richter, Ardeschir Ghofrani, Christian Müller
Publikováno v:
16. Deutscher Kongress für Versorgungsforschung (DKVF); 20171004-20171006; Berlin; DOCP100 /20170926/
Ventavis is an effective therapy for patients with PAH, improving exercise capacity and symptoms. Ventavis nebuliser solution for inhalation is available as 10 µg/mL (V10) and 20 µg/mL (V20) formulations, administered using the I-Neb nebulizer. Som
Autor:
Ariana Kariminejad, Yun Li, Raoul C.M. Hennekam, Nina Bögershausen, Barbara Stollfuß, Karin Boss, Bernd Wollnik
Publikováno v:
American journal of medical genetics. Part A, 161AA(6), 1475-1479. Wiley-Liss Inc.
Limb patterning and growth are complex embryonic processes in which the elaborately orchestrated interplay of diverse endocrine and paracrine factors is crucial to limb integrity. LRP4 is a lipoprotein receptor known for its regulatory effects on LRP